Lupin Responds To FDA Warning Letter

US Agency Criticized Novel Laboratories Facility In New Jersey

 
• By David Wallace
  
Lupin logo magnifying glass
Lupin is under scrutiny from the FDA • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Business